Connection
Kyle Rove to Anti-Inflammatory Agents, Non-Steroidal
This is a "connection" page, showing publications Kyle Rove has written about Anti-Inflammatory Agents, Non-Steroidal.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.023 |
|
|
|
-
Xiang AH, Hwang CK, Clennon E, To T, Pyrzanowski J, Calderon AB, Wilson S, Shields E, Beltran G, Sevick C, Bock M, Harris KT, Rove KO. Safety of short-term non-steroidal anti-inflammatory drug use in the postoperative setting in paediatric patients with chronic kidney disease: protocol for a randomised, placebo-controlled trial. BMJ Open. 2026 Sep 18; 16(9):e120782.
Score: 0.774
-
Ha D, Halstead NV, Blanchette ED, Wilcox DT, Vemulakonda VM, Wood DN, Rove KO. Risk of acute kidney injury after lower urinary tract reconstruction with early NSAID therapy: A propensity matched retrospective analysis. J Pediatr Urol. 2024 10; 20(5):911-920.
Score: 0.666
-
Rove KO, Halstead NV, Wiesen BM, Bielsky AR, Campbell JB. Randomized controlled trial of NSAID prior to cystoscopic ureteral stent removal in a pediatric population. J Pediatr Urol. 2022 Oct; 18(5):679.e1-679.e9.
Score: 0.582
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|